Leaflet SOMATULINE PR 30mg lyophilisate and solvent for solution for injection
Indicated for: acromegaly; neuroendocrine tumors
Route of administration: injectable
Substance: lanreotide (somatostatin analogue)
ATC: H01CB03 (Systemic hormonal preparations, excluding sex hormones and insulins | Hypothalamic hormones | Somatostatin and analogues)
Use during pregnancy only on medical advice.
Lanreotide is a somatostatin analog used to treat acromegaly and certain neuroendocrine tumors. It works by inhibiting the secretion of hormones such as growth hormone and reducing blood flow to neuroendocrine tumors.
The medication is administered as subcutaneous injections, usually once every 4 weeks, as directed by a doctor. The treatment is effective in controlling symptoms and slowing disease progression.
Side effects may include pain at the injection site, nausea, diarrhea, or fatigue. In rare cases, severe allergic reactions or gallstone formation may occur.
Patients should strictly follow their doctor's instructions and inform them about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.
General data about SOMATULINE PR 30mg
- Substance: lanreotide
- Date of latest medicines list: 01-01-2014
- Product code: W12079001
- Concentration: 30mg
- Pharmaceutical form: lyophilisate and solvent for solution for injection
- Quantity: 1
- Product type: Original
- Prescription status: S - Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.
Concentrations available for lanreotide
- 120mg
- 30mg
- 60mg
- 90mg